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Abstract
Lipopolysaccharide (LPS) is a major component on the surface of Gram negative bacteria and is composed of lipid A-core
and the O antigen polysaccharide. O polysaccharides of the gastric pathogen Helicobacter pylori contain Lewis antigens,
mimicking glycan structures produced by human cells. The interaction of Lewis antigens with human dendritic cells induces
a modulation of the immune response, contributing to the H. pylori virulence. The amount and position of Lewis antigens in
the LPS varies among H. pylori isolates, indicating an adaptation to the host. In contrast to most bacteria, the genes for H.
pylori O antigen biosynthesis are spread throughout the chromosome, which likely contributed to the fact that the LPS
assembly pathway remained uncharacterized. In this study, two enzymes typically involved in LPS biosynthesis were found
encoded in the H. pylori genome; the initiating glycosyltransferase WecA, and the O antigen ligase WaaL. Fluorescence
microscopy and analysis of LPS from H. pylori mutants revealed that WecA and WaaL are involved in LPS production. Activity
of WecA was additionally demonstrated with complementation experiments in Escherichia coli. WaaL ligase activity was
shown in vitro. Analysis of the H. pylori genome failed to detect a flippase typically involved in O antigen synthesis. Instead,
we identified a homolog of a flippase involved in protein N-glycosylation in other bacteria, although this pathway is not
present in H. pylori. This flippase named Wzk was essential for O antigen display in H. pylori and was able to transport
various glycans in E. coli. Whereas the O antigen mutants showed normal swimming motility and injection of the toxin CagA
into host cells, the uptake of DNA seemed to be affected. We conclude that H. pylori uses a novel LPS biosynthetic pathway,
evolutionarily connected to bacterial protein N-glycosylation.
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Introduction
Lipopolysaccharide (LPS) is a prevalent macromolecule in the
outer membrane of Gram negative bacteria and represents an
important virulence factor. LPS is composed of three parts: lipid A
which is embedded in the outer membrane, the core oligosaccha-
ride, and the O antigen [1]. Lipid A is also known as endotoxin,
which refers to the induction of fatal reactions of the human
immune system at very low LPS concentrations. Bound to lipid A
is the core oligosaccharide, which is relatively well conserved
among closely related bacteria. The O antigen represents the
outermost region of the LPS.
The O antigen of Helicobacter pylori contributes in several respects
to the virulence of this human gastric pathogen, which is
recognized by the World Health Organization as a Type 1
carcinogen [2]. H. pylori mimics carbohydrate structures present on
human epithelial cells, blood cells, and in secretions, by
incorporating Lewis antigens on its O chains [3]. In most strains,
both, Lewis x (Le
x) and Lewis y (Le
y), can be found in certain
regions of the O antigen. Some strains also display Lewis a (Le
a)
and b (Le
b) antigens or can have alternative O antigen structures
[4]. H. pylori profits from this molecular mimicry, as Le
x and Le
y
interact with the C-type lectin DC-SIGN on dendritic cells, which
signals the immune system to down-regulate an inflammatory
response [5]. The amounts of Lewis antigens and their location on
the H. pylori O polysaccharide are variable, differing between
strains and also between cells from the same isolate [3,6]. This is
due to the phase variable expression of the H. pylori fucosyl-
transferases, enzymes required for the synthesis of Lewis antigens
[7]. Evidence suggests that the O antigen structures of H. pylori
strains are adapted to the individual human host, enabling the
establishment of a chronic infection [8,9].
Unlike most bacteria, the genes involved in LPS biosynthesis in
H. pylori are not arranged in a single cluster, but rather found in
various locations distributed throughout the chromosome. Never-
theless, many enzymes required for H. pylori LPS biosynthesis have
been identified and characterized. These include glycosyltransfer-
ases responsible for the addition of the monosaccharide building
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proteins involved in the synthesis and modification of the lipid
A-core [10]. The pathway used for the assembly and translocation
of the O antigen in H. pylori remained uncharacterized.
In all characterized LPS biosynthetic pathways, the O poly-
saccharide is assembled onto the undecaprenyl phosphate (UndP)
lipid carrier by specific glycosyltransferases located in the cytoplas-
mic compartment of the bacteria [1]. Several initiating enzymes
have been characterized that transfer a sugar phosphate from a
nucleotide activated donor to UndP, forming a pyrophosphate
linkage. One of the common initiating enzymes is WecA, a UDP-
GlcNAc:undecaprenyl-phosphate GlcNAc-1-phosphate transferase
[11,12]. Other glycosyltransferases sequentially add monosaccha-
rides at the non-reducing end of the growing glycan chain. The
lipid-linked glycan is subsequently translocated to the periplasm
where the O polysaccharide is transferred from undecaprenyl
pyrophosphate (UndPP) onto the lipid A-core. This last step is
catalyzed by the O antigen ligase WaaL.
Three LPS biosynthesis pathways are known to date [1]. They
are distinguished by three different mechanisms for O antigen
polymerization and translocation. In the polymerase-dependent
pathway, only short O antigen subunits are assembled in the
cytoplasm. These subunits are translocated to the periplasm by the
flippase Wzx, where they are polymerized by Wzy with assistance of
the chain length regulator Wzz, before the complete O antigen is
transferred to the lipid A-core. In the two remaining pathways, the
ABC transporter-dependent and the synthase-dependent pathway,
the entire O polysaccharide is synthesized at the cytoplasmic side of
the inner membrane. The flippase in the ABC transporter-
dependent pathway consists of two different polypeptides, Wzm
and Wzt. Wzm forms a channel in the inner membrane for the
passage of the lipid-linked O antigen, and Wzt provides energy
through its ATPase activity. The C-terminal domain of Wzt is
required for substrate recognition, and often displays specificity
towards the structure of the endogenous O chain [13]. In the third
pathway, the key enzyme is the synthase WbbF, which has
glycosyltransferase activity and is also required for the transloca-
tion of the UndP-linked O antigen to the periplasm [1]. Some
exopolysaccharides and capsules are synthesized via pathways that
resemble one of these three LPS biosynthesis pathways [14].
In some Gram negative bacteria, including Campylobacter jejuni
which is closely related to H. pylori, the cell surface is covered with
lipooligosaccharides (LOS) instead of LPS [1]. LOS and LPS are
equivalent macromolecules; however, LOS lacks the O polysac-
charide and is limited to a short oligosaccharide bound to the lipid
A-core [1]. Generally, the oligosaccharide moiety is directly
assembled onto the lipid A in the cytoplasm and UndP is not
required for LOS biosynthesis.
The goal of this investigation was to determine the pathway used
by H. pylori for the assembly of the Lewis antigens onto the lipid
A-core. We found that these polysaccharides are assembled
as typical O antigens onto the UndP carrier. Surprisingly, for the
membrane translocation of the lipid-linked glycan, H. pylori employs
an enzyme which has not been previously found to be involved
in LPS synthesis, but instead is used by other bacteria in the
biosynthesis of N-glycoproteins. This translocase, named Wzk, has
no strict structural requirement for its substrates, a characteristic
thatenablesH.pyloritoproduceOantigensofvariousstructuresand
lengths according to the phenotype of the infected host.
Results
The H. pylori genome encodes common LPS biosynthesis
enzymes: WecA and WaaL
In order to identify genes possibly involved in H. pylori LPS
biosynthesis, a genome search was performed using the sequences
of enzymes known to participate in LPS biosynthetic pathways.
The search resulted in the identification of homologs of the E. coli
wecA and waaL genes. The proteins encoded in the H. pylori genes
JHP1488 in strain J99 and HPG27_1518 in strain G27 are 22%
identical to E. coli WecA and 94% identical to each other. The
genes JHP0385 and HPG27_389 encode polypeptides which are
19% identical to the O antigen ligase WaaL and 95% identical to
each other. The overall homology between WecA and WaaL
sequences from different organisms is low. Nevertheless these
proteins, including the H. pylori homologs identified, share similar
membrane topologies and a few conserved key residues. Align-
ments of the protein sequences are shown in Figure S1 and S2.
Intriguingly, the H. pylori genome seemed to lack homologs of wzx,
wzt, wzm or wbbF, which encode the flippase proteins involved in
O antigen translocation in the known pathways. Furthermore,
sequences encoding an O antigen polymerase Wzy, or a chain
length regulator Wzz could not be found. Thus, the canonical LPS
pathways are incomplete in H. pylori.
To address whether the identified genes were indeed involved in
H. pylori LPS biosynthesis, mutants in both H. pylori strains, J99 and
G27, were constructed by inserting a chloramphenicol-resistance
cassette into the putative wecA and waaL open reading frames. For
the generation of complemented strains, each gene was re-
introduced into the recA gene on the chromosome of the
corresponding mutant strain. This location in the genome was
selected to prevent further recombinations, a procedure expected
to stabilize the mutations. We took advantage of the H. pylori
natural competence for the construction of the mutant strains.
Interestingly, this procedure was not successful for the generation
of complemented strains, as no colonies were recovered on the
selective plates after transformation. However, complemented cells
were efficiently obtained by electroporation.
Monoclonal antibodies reacting with Lewis antigens were
used to visualize the presence or absence of O antigens on the
cell surfaces by fluorescence microscopy (Figure 1). Not all wild
type cells reacted with the antibody (Figure 1B). This is due to the
Author Summary
Bacterial surfaces are decorated with glycans. The human
stomach pathogen Helicobacter pylori exposes lipopoly-
saccharide (LPS) containing Lewis antigens that mimic
human glycan structures. H. pylori alters its Lewis antigen
display in adaptation to the individual host. Lewis antigens
can interact with human dendritic cells, thereby inducing a
suppression of the immune response and facilitating a
chronic H. pylori infection. Whereas three general LPS
biosynthesis pathways are known, the route of LPS
assembly in H. pylori remained to be elucidated. We
identified and characterized two components of the H.
pylori LPS pathway, WecA and WaaL, which demonstrated
that, as in other bacteria, the glycan is initially assembled
onto a polyprenoid lipid carrier. This intermediate then
has to cross a membrane barrier, requiring specialized
translocases. H. pylori does not employ a translocase from
common LPS pathways. We show that instead H. pylori
uses a translocase named Wzk, which is involved in protein
N-glycosylation in other bacteria. Wzk was able to trans-
locate various glycan structures. The identification of Wzk
as the H. pylori translocase involved in LPS biosynthesis
indicates an evolutionary connection between LPS and
glycoprotein biosynthesis pathways.
Helicobacter pylori LPS Pathway
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(0.2–0.5%) reported by Appelmelk et al. [15]. Lewis antigens could
also be detected on flagella (Figure S3), confirming the presence of
LPS in the membranous sheaths covering these organelles [16].
This was shown previously by electron microscopy [17] but, to our
knowledge, not by fluorescence microscopy. Importantly, all the
mutant cells were devoid of Lewis antigens (Figure 1D, F),
suggesting the participation of the putative WecA and WaaL in H.
pylori LPS biosynthesis.
To obtain further evidence for the involvement of the putative
WecA and WaaL in H. pylori LPS biosynthesis, the LPS of all
strains was purified, separated by SDS-PAGE and visualized by
silver staining (Figure 2A) and Western blotting, using monoclonal
anti-Le
x (Figure 2B) and anti-Le
y antibodies (Figure 2C). Only
rough LPS without O chains and Lewis antigens was produced by
the mutant strains (Figure 2, lanes 2, 4), demonstrating that both
targeted genes are essential for O antigen display. However,
whereas the complementation of the putative wecA mutants was
successful, the production of smooth LPS was restored only at
minimal levels after reintroduction of the putative waaL gene into
the chromosome of the waaL mutant strain (Figure S4).
Based on the evidence presented we annotated JHP1488 and
HPG27_1518 as wecAHP. Similarly, JHP0385, as well as
HPG27_389 were named waaLHP.
WecAHP is active in E. coli
The availability of E. coli strains with specific mutations in LPS
biosynthesis genes allowed us to test for activity of WecAHP and
WaaLHP by recombinant expression in these mutant strains. E. coli
strains carrying either a mutation in wecA or waaL were
transformed with plasmids carrying the corresponding H. pylori
homolog gene (pIH22 and pIH52, respectively). As shown in
Figure 3, wecAHP complemented O antigen synthesis in the E.
coli wecA mutant, which confirms its role as a UDP-GlcNAc:
undecaprenyl-phosphate GlcNAc-1-phosphate transferase.
On the contrary, although WaaLHP could be expressed in E.
coli, it was unable to restore smooth LPS production in an E. coli
waaL mutant (data not shown). The transfer of O antigens onto the
Figure 1. H. pylori wecA, waaL and wzk mutant cells display no Lewis antigens. Fluorescence microscopy of H. pylori G27 was performed
using monoclonal antibodies against Lewis antigens. Panels A, C, E, G, I and K show phase contrast images, whereas panels B, D, F, H, J and L show
bacteria displaying Le
y based on reaction with the anti-Le
y antibody. Equivalent results were obtained with the anti-Le
x antibody (not shown). Lewis
antigens are not present on all wild type H. pylori cells due to phase variable fucosyltransferases. The bars in the lower right corners of the pictures
indicate 10 mm. The images are representative for the results obtained from three independent experiments.
doi:10.1371/journal.ppat.1000819.g001
Helicobacter pylori LPS Pathway
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heterologous expression of O antigen ligases is therefore often
not functional [1,18,19]. E. coli and H. pylori core regions are
structurally different [20], which could explain the lack of activity
of WaaLHP in E. coli.
H. pylori WaaL is active in vitro
As full complementation of the H. pylori waaLHP mutant strain
could not be achieved and the enzyme was not functional with the
E. coli lipid A-core as an acceptor, we tested O antigen ligation
activity by performing an in vitro assay. WaaLHP containing a C-
terminal deca-His tag (encoded in pIH52) was expressed in the E.
coli waaL mutant strain CLM24 [21]. Expression in this strain was
selected to prevent possible contamination with the E. coli O
antigen ligase. Membranes containing the enzyme were solubilized
with detergents and WaaLHP was purified by nickel affinity
chromatography as described in Material and Methods (Figure
S5). As the band corresponding to purified protein had an
apparent molecular weight of about 36 kD instead of the expected
50 kD, the identity of the polypeptide was confirmed by mass
spectrometry. As seen with silver staining (Figure 4A, lane 1), lipid
A-core from E. coli co-purified with the H. pylori ligase. Lipid A-
core from the H. pylori waaLHP mutant strain was purified and used
as an acceptor structure. O antigen ligases typically show relaxed
specificity towards the structure of the O polysaccharide [1], a
property that allows the use of diverse UndPP-linked glycans as
substrates for the in vitro assay. Due to the presence of multiple
bands, LPS containing a polymerized O antigen is often
indistinguishable from the corresponding UndPP-bound O
antigen in SDS-PAGE and Western blot analysis. We reasoned
that the use of a short oligosaccharide of defined length would
facilitate the interpretation of results. Therefore, the UndPP-linked
heptasaccharide derived from the C. jejuni N-linked protein
glycosylation pathway was selected as substrate. This lipid-linked
glycan can be synthesized in E. coli cells carrying the plasmid
pACYCpglBmut [22], which contains all the enzymes required for
the assembly of the heptasaccharide, and has been successfully
shown to be a suitable substrate for in vitro glycosylation [23,24].
All reactantswere mixed and incubated at 37uCovernight. Reaction
products appeared as bands of higher molecular weight in SDS-PAGE
(Figure 4A, lane 4) and positively reacted with the HR6 antibody,
which recognizes the C. jejuni heptasaccharide (Figure 4B, lane 4). The
reaction mixtures were subjected to mild acid hydrolysis. In such
conditions, the reaction product is stable, whereas the substrate is
hydrolyzed (Figure S6). After acid hydrolysis, the HR6-reacting bands
corresponding to LPS were still present (Figure 4C, lane 4), whereas the
bands corresponding to the UndPP-linked heptasaccharide substrate
were no longer observed (Figure 4C, lanes 2, 4, 5, 7). These results
demonstrated the successful transfer of the C. jejuni heptasaccharide
onto the H. pylori lipid A-core acceptor, thereby confirming the O
antigen ligase activity of WaaLHP.TheE. coli lipid A-core present in the
fraction containing the recombinant H. pylori ligase was not an
appropriate WaaLHP acceptor, as activity was dependent on the
presence of H. pylori lipid A-core (Figure 4, lanes 4, 7).
It is notable that unlike the O antigen ligase of Pseudomonas
aeruginosa [19], WaaLHP did not require ATP as an energy source.
The presence or absence of ATP in the in vitro reaction did not
noticeably affect ligation efficiency (Figure S7).
H. pylori encodes an O antigen translocase usually
involved in protein N-glycosylation
From the previous experiments we concluded that the H. pylori
LewisantigensaresynthesizedontotheUndPPcarrierviaapathway
Figure 2. LPS of H. pylori wecA and waaL mutant strains contains
no O antigens. Purified LPS of (1) H. pylori G27 wild type, (2) wecA
mutant, (3) wecA complemented and (4) waaL mutant strains were
analyzed by (A) silver staining, and Western blotting using (B) monoclonal
anti-Le
x and (C) monoclonal anti-Le
y antibodies. Protein marker standards
were included for reference. Unlike the smooth LPS of the wild type and
complementedstrains,mutantsexpressedlipidA-corewithoutOantigens.
Comparable results were obtained with purified LPS from H. pylori J99
strains (not shown).
doi:10.1371/journal.ppat.1000819.g002
Figure 3. Demonstration of WecAHP activity in E. coli. Purified LPS
from (1) E. coli parental strain W3110 transformed with pMF19, encoding
a functional rhamnosyltransferase, (2) E. coli wecA mutant strain CLM37
transformed with pMF19 and empty vector pEXT20 and (3) CLM37
transformedwith pMF19andpIH22 containingwecAHP, were analyzedby
(A) silverstaining and(B) Western blotting using an antibody recognizing
the E. coli O16 antigen. Protein marker standards were included for
reference.
doi:10.1371/journal.ppat.1000819.g003
Helicobacter pylori LPS Pathway
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glycans onto the lipid A-core. It was puzzling that no gene encoding
one of the common O antigen translocases could be found in the H.
pylori genome. Therefore, we searched for the presence of alternative
flippases belonging to other biosynthetic pathways.
A gene homolog to pglK (formerly named wlaB) which encodes a
flippase involved in the translocation of the UndPP-linked
heptasaccharide during protein N-glycosylation in C. jejuni [25]
was found in the H. pylori genome. The genes annotated as
JHP1129 in strain J99 and HPG27_1153 in strain G27 encode
polypeptide sequences which are 97% identical to each other and
share 37% identity with C. jejuni PglK (see alignments in Figure
S8). No evidence for the presence of N-glycoproteins has been
found in H. pylori, and therefore, the homolog of C. jejuni PglK was
our principal candidate as the H. pylori O antigen translocase.
We investigated the flippase activity of the putative H. pylori
translocasethrough complementation experiments in E. coli described
by Alaimo et al. [25]. A gene cluster encoding the complete C. jejuni N-
linked protein glycosylation machinery, which includes the PglK
flippase, was introduced into an E. coli mutant strain devoid of known
glycan flippases. These cells were also transformed with plasmid
pIH18expressingAcrA,aC. jejuniacceptor proteinthatcarriestwo N-
glycosylation sites. Glycosylation of AcrA in E. coli was detected
through the appearance of two extra bands of higher molecular
weight in Western blots, immunoreactive to the AcrA and the C.jejuni
glycan-specific HR6 antibodies (Figure 5A, B). Glycosylation of AcrA
was abolished when the translocase PglK was absent (Figure 5A, B,
lane 2), but was restored in the presence of the putative H. pylori
translocase encoded in pIH23 (Figure 5A, B, lane 3), indicating that
the activities of PglK and its H. pylori homolog (named Wzk,
according to the current official nomenclature of LPS genes [26]) are
interchangeable. Further evidence of the Wzk translocase activity was
obtained by demonstrating its capability to restore the flipping of O
a n t i g e ni na nE. coli wzx mutant strain (Figure 5C, D, lane 3). Taken
together, these results indicate that Wzk is a translocase for UndPP-
linked glycans, equivalent to PglK. Structurallydifferent glycans were
translocated by Wzk (Figure S9), indicating a relaxed substrate speci-
ficity of this enzyme.
To demonstrate the involvement of Wzk in H. pylori LPS
biosynthesis, the wzk gene was mutated as described previously for
wecAHP and waaLHP. Fluorescence microscopy showed that Lewis
antigens were not present on the surface of H. pylori wzk mutant
cells (Figure 1J). The absence of Le
x and Le
y antigens on purified
LPS from the mutant strain was shown by Western blot analysis
(Figure 6B, C, lane 2). SDS-PAGE followed by silver staining
showed that the LPS of the wzk mutant did not contain O antigens
(Figure 6A, lane 2). Upon complementation with either wzk or its
homolog pglK, the synthesis of smooth LPS was restored (Figure 6,
lanes 3, 4). Taken together, these results demonstrated that Wzk is
an essential component in the LPS biosynthesis pathway in H.
pylori, responsible for the translocation of the O antigen. Although
in their native hosts PglK and Wzk participate in different
pathways, both enzymes can be functionally exchanged, being
able to translocate glycans of diverse structures and lengths.
O antigen is not required for H. pylori motility
Our fluorescence microscopy experiments allowed us to confirm
the presence of LPS on the membranous sheaths covering H. pylori
flagella, raising the possibility of a connection between LPS integrity
and motility. We tested this hypothesis by comparing the swimming
activity of the O antigen deficient strains relative to the wild type
strains. After growth on soft agar plates, no significant difference
between the diameters of colony expansion was detected (results not
shown). It was concluded that the absence of O antigens in the H.
pylori LPS has no adverse effect on flagellar function in vitro.
H. pylori O antigen mutation may adversely affect
selected type IV secretion systems
As mentioned above, the protocol for natural DNA uptake was
not successful in the construction of the complemented strains.
Figure 4. Demonstration of WaaLHP activity in vitro. Mixtures with purified WaaLHP, H. pylori lipid A-core (acceptor) and C. jejuni UndPP-linked
heptasaccharide (LLO; substrate) were incubated overnight. (1) WaaLHP only, (2) substrate only, (3) acceptor only, (4) all components, (5) no WaaLHP,
(6) no substrate, (7) no acceptor. Reaction products were detected by (A) silver staining and (B) Western blotting using an antibody reactive against
the C. jejuni heptasaccharide (HR6). (C) Western blotting after removal of the substrate by mild acid hydrolysis confirmed the presence of
heptasaccharide attached to lipid A-core, as this reaction product is not affected by the acid treatment. Arrows indicate the reaction product.
Contaminating E. coli lipid A-core co-purified with WaaLHP (A, lane 1, 4, 6, 7). Note that the E. coli and H. pylori lipid A-cores as well as the C. jejuni LLO
present similar electrophoretic mobilities. Protein marker standards were included for reference.
doi:10.1371/journal.ppat.1000819.g004
Helicobacter pylori LPS Pathway
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pylori O antigen mutants. The natural competence of H. pylori
depends on the ComB type IV secretion system [27]. As H. pylori
possesses additional type IV secretion systems, we examined if the
presence of O antigens on the bacterial surface might be required
for the function of these machineries. One additional H. pylori type
IV secretion system is encoded in the cag pathogenicity island [28].
The presence of this gene cluster in H. pylori correlates with
enhanced virulence, as the Cag type IV secretion system builds a
needle-like device for the injection of a single known effector
protein, CagA, directly into the host cells. Within the host, CagA is
tyrosine phosphorylated and interferes with cell signaling pathways
[28].
We compared the efficiency of CagA injection into human
gastric epithelial cells between wild type and O antigen mutant H.
pylori strains. AGS gastric epithelial cells were infected with H.
pylori cells from an overnight grown liquid culture. Cells were
harvested four hours after infection, when many epithelial cells
displayed an elongated morphology, a typical effect following
CagA translocation [28]. AGS cell membrane fractions were
collected and analyzed by Western blotting, using anti-CagA
(Figure 7A) and anti-phosphotyrosine (Figure 7B) antibodies. All
H. pylori strains injected similar amounts of CagA. We concluded
that mutations interfering with the synthesis of smooth LPS in H.
pylori may reduce natural competence, but do not affect type IV
secretion systems in general.
Discussion
With the display of Lewis antigens on the O chains, the LPS
plays a unique role in H. pylori colonization. The fact that the genes
involved in LPS biosynthesis are not grouped in a single locus in
the H. pylori chromosome is probably one of the reasons why the
pathway for the biosynthesis of this key macromolecule remained
to be determined. The objective of this investigation was to
elucidate the LPS biosynthetic pathway in H. pylori. Genomic
analysis revealed that none of the previously characterized
pathways for LPS biosynthesis is complete in H. pylori, suggesting
that this bacterium uses an alternative strategy. One possibility was
that the synthesis of LPS took place directly on the lipid A-core as
it occurs with the LOS biosynthesis in C. jejuni and Neisseria spp.
[1]. However, using a combination of genetic, biochemical and
microscopy techniques, we showed that the O antigen is assembled
onto a polyisoprenoid lipid carrier. Figure 8 illustrates our model
of H. pylori LPS biosynthesis. WecAHP initiates this pathway by
transferring a GlcNAc-phosphate from UDP-GlcNAc to UndP.
The resulting molecule, UndPP-GlcNAc, serves as an acceptor for
the assembly of the O chain backbone, composed of alternating
GlcNAc and Gal residues. Some of these linear polysaccharides
Figure 5. H. pylori has a flippase able to translocate diverse
UndPP-linked glycans. Activity of the H. pylori translocase was
examined with complementation assays in flippase deficient E. coli. (A,
B) Glycosylation of the acceptor protein AcrA in the N-glycosylation
pathway of C. jejuni was analyzed by Western blotting with (A) anti-AcrA
antibody and (B) an antibody (HR6) recognizing the C. jejuni glycan. C.
jejuni pglK was (1) functional, (2) mutated, or (3) mutated and
complemented by H. pylori wzk. (C, D) Purified LPS of E. coli strains
containing (1) a functional flippase Wzx, (2) a wzx mutation or (3) a wzx
mutation complemented by wzk, was visualized by silver staining and
Western blotting using an antibody recognizing the E. coli O16 antigen.
Protein marker standards were included for reference.
doi:10.1371/journal.ppat.1000819.g005
Figure 6. Wzk is the H. pylori O antigen flippase and can be
replaced by C. jejuni PglK. Purified H. pylori LPS was analyzed by (A)
silver staining and Western blotting using (B) anti-Le
x and (C) anti-Le
y
monoclonal antibodies. Lane 1 shows smooth LPS extracted from wild
type H. pylori G27 cells; lane 2 LPS from the G27 wzk mutant strain not
containing O antigens; smooth LPS production is restored in the wzk
complemented strain shown in lane 3. Shown in lane 4: the C. jejuni
flippase PglK can functionally complement the H. pylori Wzk, and
restore a smooth LPS phenotype in the H. pylori G27 wzk mutant.
Protein marker standards were included for reference.
doi:10.1371/journal.ppat.1000819.g006
Helicobacter pylori LPS Pathway
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fucosyltransferases, producing the Lewis antigens [4]. After
translocation to the periplasm by Wzk, the O chain is attached
onto the lipid A-core acceptor by the action of the O antigen ligase
WaaLHP.
H. pylori LPS biosynthesis follows a novel pathway, differing
from all the established LPS pathways in the translocation of the O
chain. We found that this step is accomplished by Wzk, which is
not related to any described translocase involved in O antigen
synthesis. Instead, Wzk is homolog to C. jejuni PglK, responsible for
UndPP-heptasaccharide flipping during protein N-glycosylation.
Wzk and PglK are related to the lipid A-core flippase MsbA, with
the closest sequence similarity among known ATP transporters.
ATPase activity of PglK has been reported by Alaimo et al. [25].
As the C-terminal Walker domains are well conserved between
PglK and Wzk, Wzk most likely also possesses ATPase activity. All
ABC transporter-dependent LPS pathways described to date
require two polypeptides, Wzm and Wzt, for the translocation of
the O chains [1]. The only homology of these proteins to Wzk is
found in the ATP binding domains of Wzt. Wzm possesses several
transmembrane domains and is proposed to form a channel in the
inner membrane. Wzt provides the energy for the flipping
mechanism through its ATPase activity. In H. pylori, the flippase
Wzk is the only polypeptide required and sufficient for
translocation of UndPP-linked glycans. The ability of Wzk to
translocate Lewis antigens, the C. jejuni heptasaccharide, as well as
the E. coli O16 antigen, demonstrates that Wzk activity is
independent of the length or the composition of the translocated
UndPP-linked sugars.
In most bacteria, the genes involved in O antigen biosynthesis are
clustered in a single locus, which facilitates horizontal gene
exchange and regulation of O antigen synthesis [1]. In contrast,
the three genes investigated in this work, as well as the other genes
involved in O antigen biosynthesis in H. pylori, are located in
separate loci dispersed along the chromosome. H. pylori exhibits
a high rate of DNA uptake and genetic variability [29]. An
independent location of the genes requires individual gene
regulation, which could be beneficial for H. pylori by allowing more
diversity and flexibility in the LPS structure. It is particularly
intriguing that the position of the H. pylori wzk gene is located in
close proximity to tRNA genes, which are known to be hot-spots for
the insertion of mobile genetic elements [30]. On the contrary in C.
jejuni, PglK is encoded as part of the pgl-cluster, responsible for N-
linked protein glycosylation [22]. Interestingly, the oligosaccharyl-
transferase PglB, also encoded in the pgl-locus, has homologs in
eukaryotes and archaea but not in H. pylori, which does not possess
this general glycosylation machinery [31]. Different scenarios can
be advanced to describe the origin of the Wzk-like translocases. H.
pylori may have discarded its pgl-cluster, yet retained wzk to act on
the synthesis of LPS. Alternatively, the wzk gene could have been
adopted by other epsilon- or delta proteobacteria to produce N-
glycoproteins. Subsequently, some of these organisms, like C. jejuni,
may have lost their LPS cluster, producing LOS instead. In either
case, bacteria appear to favor the dedication of their lipid-linked
glycans exclusively to one biosynthetic pathway, either protein
glycosylation or LPS biosynthesis.
We encountered difficulties with natural transformation of O
antigen mutant H. pylori cells and electroporation was required for
the construction of strains for complementation experiments. One
possible explanation is a loss of natural competence for DNA
uptake. A similar observation has been reported for a C. jejuni LOS
mutant strain [32]. However, in another study C. jejuni LOS and
capsule mutants displayed increased DNA uptake ability [33].
Although the exact role of O chains in H. pylori natural competence
remains unclear, we demonstrated that the presence of O antigens
does not have a general inhibitory effect on H. pylori type IV
secretion systems, because the type IV secretion apparatus encoded
in the cagpathogenicity island was functional inO chaindeficient H.
pylori mutants. Alternatively, the lack of O antigens may induce a
stress response, resulting in the induction of DNA restriction
enzymes,which could digest the foreign DNA beforeor after uptake
into the cells.
Due to the presence of LPS on the H. pylori flagella, we
investigated the possible role of O antigens in motility. H. pylori
mutant strains were not defective in in vitro swimming motility
compared to wild type strains. However, the presence of LPS on
the flagellar surface may still play a role in vivo. The O antigens
may have a protective function by shielding the flagella against
components of the host immune defense, and by actively down-
regulating flagellin-specific activation of the innate immune system
via the interaction between Lewis antigens and DC-SIGN.
A central role of the Lewis antigens in H. pylori pathogenicity is
their interaction with DC-SIGN, which results in modulation of
the host immune defense [5]. As Lewis antigen expression is phase
variable due to the reversible switching off of the fucosyltrans-
ferases, H. pylori maintains a balance between activation and
repression of the host immune system [9]. In addition, the
fucosylated locations along the O chain backbone are finely
adapted to the host phenotype [8]. With this mechanism, a
permanent infection can be established, which in rare cases results
in gastric cancer. The O antigen translocase Wzk, which we show
here is essential for the cell surface expression of Lewis antigens,
could be an attractive target for the design of antibiotics effective
against H. pylori and possibly C. jejuni infections.
Interestingly, Wzk is the first protein common to both, LPS
biosynthesis and protein N-glycosylation, supporting an evolution-
ary connection between these pathways.
Figure 7. CagA translocation is functional in O antigen
negative H. pylori strains. Human gastric epithelial AGS cells were
infected with H. pylori G27 (1) wild type, (2) wecA mutant, (3) wzk
mutant, or (4) waaL mutant strains. (5) Non-infected AGS cells served as
negative control. AGS membranes were examined for translocation and
tyrosine phosphorylation of CagA by Western blotting using (A) anti-
CagA antibody and (B) anti-phosphotyrosine (pY) antibody. (C) The host
membrane marker h-Met was detected with an anti-h-Met antibody for
a loading control. Arrows indicate full length phosphorylated CagA. A
protein marker standard was included for reference.
doi:10.1371/journal.ppat.1000819.g007
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Genome analysis
NCBI BLASTP (default settings) was used for the search of
putative WecA, WaaL and lipid-linked glycan translocase polypep-
tide sequences encoded in the H. pylori genome. Global sequence
identities were calculated with LALIGN (default settings, global)
(http://www.ch.embnet.org/software/LALIGN_form.html).
PCR and plasmid construction
Oligonucleotides used for DNA amplification are listed in
Table S1.
Plasmids containing wecAHP. For the construction of pIH22,
wecAHP was amplified by PCR, using the primers WecAHPEcoRIfw
and WecAHPH6XbaIrv and genomic DNA from H. pylori J99 as
template. The wecAHP PCR product was cloned into pEXT20 [34],
using the restriction enzymes EcoRI and XbaI (all restriction enzymes
were purchased from New England Biolabs unless indicated
otherwise). pIH22 was used for the expression of WecAHP in E. coli.
The primers WecA_forward and WecA_reverse were used to
amplify wecAHP from H. pylori J99, which was cloned into pGEM-T
(Promega), generating pGEM-HPwecA. The obtained plasmid was
digested with SgfI (Promega), which is cutting the open reading
frame of wecAHP. Blunt ends were generated with a Klenow fra-
gment (New England Biolabs). Insertion of a chloramphenicol-
resistance cassette (CAT), derived from plasmid DT3072 [35] after
digestionwithHincII,resultedinpGEM-HPwecA-CAT,whichwas
used in the construction of H. pylori wecA::cat.
The J99 wecAHP gene was amplified with the primers
NdeIHPJ99wecAfw and HPJ99wecAH6BamHIrev. The PCR
product was ligated into vector pGEM-T easy (Promega), resulting
in plasmid pIH27, which was subsequently digested with NdeI and
BamHI and cloned into vector pSK+recxorf8-flag [36] to obtain
pIH42. pIH42 was used in the construction of H. pylori wecA::cat
recA::wecA.
Plasmids containing waaLHP. Genomic DNA from H. pylori
J99 was used as template for the PCR amplification of waaLHP using
Ligase_forward and Ligase_reverse primers. The amplified DNA
sequence was cloned into pGEM-T, generating pGEM-HPwaaL.
The waaLHP gene was subsequently cut with NheI (Invitrogen) and
blunt ends were generated using a polymerase Klenow fragment.
The CAT cassette was excised from DT3072 using HincII
Figure 8. Novel LPS biosynthesis pathway in H. pylori. The figure shows a simplified illustration of the H. pylori LPS biosynthesis pathway. The
H. pylori O chains are assembled in the cytoplasm onto a polyisoprenoid membrane anchor. The O antigen synthesis is initiated by the UDP-GlcNAc:
undecaprenyl-phosphate GlcNAc-1-phosphate transferase WecA. Processive glycosyltransferases alternately add Gal and GlcNAc residues, producing
the linear O chain backbone. Fucosyltransferases then attach Fucose residues on selected locations of the O antigen backbone, generating Lewis
antigens. The flippase Wzk transfers the O polysaccharide to the periplasm, where it is attached onto the lipid A-core by the action of the O antigen
ligase WaaL. The LPS molecule can then be transported to the outer leaflet of the H. pylori outer membrane.
doi:10.1371/journal.ppat.1000819.g008
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HPwaaL, generating pGEM-HPwaaL-CAT, which was used for
the construction of H. pylori waaL::cat.
For the construction of pIH53, waaLHP from H. pylori G27 was
amplified with primers NdeIG27waaLfw and G27waaLH10Bam-
HIrv. The PCR product and pSK+recxorf8-flag were digested
with NdeI and BamHI and ligated. The resulting plasmid pIH53
was used for the construction of H. pylori waaL::cat recA::waaL.
Plasmid pIH53 was digested with NdeI, whereas pEXT20 was
digested with EcoRI. Blunt ends were generated with a Klenow
fragment and the resulting DNA fragments were further digested
with BamHI. Subsequent ligation of the DNA fragments resulted
in pIH52, which was used for the expression of WaaLHP in E. coli.
Plasmids containing wzk. The gene encoding the flippase
Wzk was amplified from genomic H. pylori J99 DNA using the
primers KpnIHPpglKfw and HPpglKH6XbaIrev. The PCR pro-
duct and pEXT20 were digested with KpnI and XbaI. Ligation of
the DNA fragments resulted in pIH23, which was used for the
expression of Wzk in E. coli.
The gene wzk in pIH23 was cut with PsiI, and the CAT cassette
from HincII-digested DT3072 was inserted by ligation. The
resulting plasmid pIH40 was used for the construction of H. pylori
wzk::cat.
The wzk gene was excised from pIH23 through digestion with
KpnI and PstI restriction enzymes. Plasmid pSK+recxorf8-flag
was digested with BamHI and NdeI. After treatment with a
Klenow fragment the restriction products were ligated to generate
pIH43, which was used for the construction of H. pylori wzk::cat
recA::wzk.
Plasmids containing C. jejuni genes. Oligonucleotides
NdeICj81116pglKfw and Cj81116pglKXbaIrv were used for the
PCR amplification of C. jejuni pglK, with the plasmid pACYCpgl
[22] serving as template. The PCR product was digested with
NdeI and XbaI and ligated into the vector pSK+recxorf8-flag,
treated with the same restriction enzymes, leading to plasmid
pIH54, used for the construction of H. pylori wzk::cat recA::pglK.
The gene acrA encoding the glycosylation acceptor protein AcrA
from C. jejuni was excised from plasmid pWA2 [21] with SfoI and
ZraI for ligation into vector pEXT21 [34], which was digested
with SmaI. The resulting plasmid was named pIH18, and used for
the expression of AcrA in E. coli.
Bacterial strains and growth conditions
H. pylori strains J99 [37] and G27 [38] served as parental strains
for the construction of O antigen mutants. H. pylori mutant strains
were generated through natural transformation with the plasmids
pGEM-HPwecA-CAT for wecA mutants, pGEM-HPwaaL-CAT
for waaL mutants and pIH40 for wzk mutants, respectively,
resulting in the disruption of the targeted genes through insertion
of a chloramphenicol resistance cassette by homologous recombi-
nation. Mutant strains were recovered as single colonies after
growth on selective plates containing chloramphenicol. Comple-
mentation was achieved through electroporation of the mutant
strains for the uptake of the plasmids pIH42 for wecA comple-
mentation, pIH53 for waaL complementation and pIH43 for wzk
complementation, respectively. Following homologous recombi-
nation, the complemented genes were inserted into the chromo-
some of the H. pylori mutant strains, disrupting the recA gene.
Complemented colonies were selected on plates containing
chloramphenicol and kanamycin. All strains were verified with
PCR analysis.
H. pylori strains were grown on brucella broth agar plates,
supplemented with 10% heat inactivated fetal bovine serum, or on
brain heart infusion agar with 10% horse serum. The antibiotics
vancomycin (5 mg/ml), cycloheximide (100 mg/ml), trimethoprim
(10 mg/ml) and amphotericin B (8 mg/ml) were added and cells
were incubated at 37uC under micro-aerobic conditions, obtained
by adding a CampyGen gas pack (Oxoid) to an anaerobic jar. O
antigen mutant strains were selected with chloramphenicol
(25 mg/ml). Kanamycin (20 mg/ml) was added for the selection
of complemented strains. Liquid cultures were grown overnight in
brucella broth supplemented with 10% heat inactivated fetal
bovine serum and the appropriate antibiotics at 37uC with
160 rpm rotation. E. coli strains were grown overnight in LB broth
at 37uC with rotation at 200 rpm.
Fluorescence microscopy
Microscope cover glasses were prepared for the attachment of
cells using (3-aminopropyl)triethoxysilane (Sigma) according to
Stra ¨hle and coworkers [39]. Overnight H. pylori cultures were
adjusted to an optical density at 600 nm wave length (OD600)o f
1.0 per ml. Cells were washed with PBS and an equivalent of 0.4
OD600 was applied to each cover glass. After 30 min of incubation
on ice, the cell suspension was removed and cells were fixed with
4% paraformaldehyde for 10 min at room temperature. Staining
and microscopy procedures were conducted as described by
Couturier and Stein [40], whereby a monoclonal anti-Le
y
antibody (1/200) (Calbiochem) and a secondary Alexa Fluor 488
goat anti-mouse antibody (1/500) (Molecular Probes) were used
for staining.
LPS analysis (immunoblotting/silver staining)
Small scale LPS extraction using hot phenol was performed
following the procedure described by Marolda et al. [41], with the
exception that ethyl ether was replaced by ethanol for the washing
of the LPS pellet. The LPS was run on a 15% SDS-PAGE and
visualized by the silver staining method described by Tsai and
Frasch [42], or by Western blotting, using monoclonal mouse anti-
Le
x and anti-Le
y antibodies (Calbiochem), or rabbit anti-O16
antigen antiserum (Statens Institute, Denmark). After incubation
with a secondary goat anti-mouse IgM IRDye-800 antibody or a
goat anti-rabbit IRDye-800 antibody, respectively (LI-COR
Biosciences), the blots were scanned with an Odyssey infrared
imaging system (LI-COR Biosciences).
Activity tests in E. coli
E. coli serogroup O16 laboratory strains produce rough LPS
without O antigen due to a mutation inactivating the rhamnosyl-
transferase responsible for the addition of the second sugar residue
in the O chain assembly. Smooth LPS production can be restored
with the addition of a plasmid pMF19 containing the rhamnosyl-
transferase gene [43]. E. coli W3110 transformed with pMF19
served as a positive control, producing long chain O16 LPS. E. coli
strain CLM37 has a mutation in wecAEC, and therefore is unable to
assemble O chains [44]. CLM37 was transformed with pMF19
and empty vector pEXT20 to serve as negative control in the
experiment testing for WecAHP activity. WecAHP activity was
examined in CLM37 transformed with pMF19 and pIH22.
The E. coli O antigen ligase mutant strain CLM24 was
transformed with pMF19 and either pIH52 or pEXT20 for the
analysis of WaaLHP activity or for the corresponding negative
control, respectively.
To test the ability of H. pylori Wzk to flip UndPP-linked glycans
in an N-glycosylation pathway, E. coli strain SCM7 [25] containing
mutations in oligosaccharide translocases was transformed with
pIH23 (containing wzk), pIH18 (encoding the acceptor protein
AcrA) and pACYCpglKmut (encoding the C. jejuni glycosylation
machinery with a mutation in the translocase gene pglK [44]). In
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transformed instead of pIH23. The positive control strain was
transformed with pACYCpgl (containing the intact C. jejuni
glycosylation machinery) instead of pACYCpglKmut. To further
examine if Wzk has O antigen translocase activity, the E. coli
flippase mutant strain CLM17 [45] was transformed with pMF19
and pIH23, or the vector control pEXT20.
LPS profiles were analyzed by silver staining as described above.
Western blotting was used to determine the glycosylation status in
the Wzk activity tests. As primary antibodies, either an anti-AcrA
antibody [22], recognizing the acceptor protein, or the antiserum
HR6 (S. Amber and M. Aebi, manuscript in preparation), reacting
with the C. jejuni glycan, were applied. After incubation with a
secondary goat anti-rabbit IRDye680 antibody (LI-COR Biosci-
ences), bands were visualized with an Odyssey imaging system (LI-
COR Biosciences).
Mass spectrometry
The protein band corresponding to the putative WaaLHP was
excised from a coomassie stained gel (Figure S5). The protein was
in-gel digested using trypsin (Promega) according to Shevchenko
et al. [46]. Peptide fragments were eluted from the gel piece,
desalted using zip-tipC18 (Millipore) according to the supplier
protocol and dissolved in 0.1% formic acid. Peptides were
separated with a LC/MSD Trap XCT (Agilent Technologies)
and the resulting mass spectrum was used for the identification of
the protein by the Mascot search engine (www.matrixscience.com)
using the NCBInr database.
WaaL in vitro assay
The E. coli O antigen ligase mutant CLM24 was transformed
with pIH52 which encodes waaLHP with a C-terminal deca-
histidine tag. Cells were grown overnight at 37uC with 0.2 mM
IPTG for the production of the O antigen ligase. The protocol
described by Faridmoayer et al. [24] for the purification of an
oligosaccharyltransferase was used for the purification of WaaLHP.
Briefly, membrane fractions were solubilized with 2% elugent
(Calbiochem) in phosphate buffer, pH 7.2. Elugent concentration
was diluted to 1% and the membrane fraction loaded unto a nickel
agarose column (Qiagen) with 20 mM imidazole. The washing
solution contained 50 mM imidazole and 0.5% DDM (Anatrace).
Ligase was eluted with 250 mM imidazole in the presence of 0.5%
DDM. The lipid A-core from waaLHP mutant cells was obtained as
described above and utilized as acceptor in the in vitro assay.
UndPP-linked glycans serving as substrates were produced by E.
coli CLM24 cells transformed with pACYCpglBmut [22]. A crude
UndPP-glycan extraction was performed according to Ielpi et al.
[47]. Purified WaaLHP (4–5 mg), purified LPS (1.2 mg, estimated
using the method described by Osborn [48]), and an extract
containing the UndPP-glycan (20% v/v) were incubated overnight
at 37u. The volume was adjusted to 50 ml with reaction buffer as
previously described for in vitro glycosylation [24] (50 mM Tris-
HCl pH 7.5, 100 mM sucrose and 1 mM MnCl2), with or without
ATP (2 mM). Reaction products were visualized by silver staining
or Western blotting using the glycan specific antibody HR6. In
addition, mild acid hydrolysis was performed similar to the
method described by Ielpi et al. [47], by incubation in 1% acetic
acid at 80uC for 30 min to destroy the pyrophosphate linkage of
the substrate.
Motility assay
H. pylori wild type and O antigen mutant cells from overnight
cultures, grown either on plates or in liquid media, were spotted on
soft brucella broth agar plates (0.3% agar) and incubated at 37uC
under micro-aerobic conditions. Swimming motility was analyzed
after 3–6 days by comparison of the colony growth diameters.
CagA translocation assay
The procedure for the CagA translocation assay was previously
described by Cendron et al. [49]. Briefly, AGS cells were grown
overnight in 10 cm culture dish plates and later infected with H.
pylori cells with a multiplicity of infection of 100:1 for four hours.
After incubation, AGS cells were washed, harvested and frac-
tionated. Membrane fractions were analyzed by Western blotting,
using anti-CagA (1:2000, kindly provided by Antonello Covacci),
and anti-phosphotyrosine (1:2000, anti-PY99, Santa Cruz Bio-
technology) antibodies. Analysis with an anti-h-Met antibody
(1:1000, C-28, Santa Cruz Biotechnology) showing the general
host membrane protein h-Met served as loading control.
Supporting Information
Figure S1 WecA alignments. Alignments of WecA polypeptide
sequences were done using MultiAlin (http://bioinfo.genotoul.fr/
multalin/multalin.html). (A) Alignments of WecA sequences from
sequenced H. pylori strains G27, 26695, J99, HPAG1 and P12. (B)
Alignment of WecA sequences from H. pylori G27 and J99 with
WecA sequences from Burkholderia cenocepacia and E. coli.
Found at: doi:10.1371/journal.ppat.1000819.s001 (0.51 MB GIF)
Figure S2 WaaL alignments. Alignments of WaaL polypeptide
sequences were done using MultiAlin (http://bioinfo.genotoul.fr/
multalin/multalin.html). (A) Alignments of WaaL sequences from
sequenced H. pylori strains G27, 26695, HPAG1, P12 and J99. (B)
Alignment of WaaL sequences from H. pylori G27 and J99 with
WaaL sequences from E. coli, Pseudomonas aeruginosa and Salmonella
typhimurium.
Found at: doi:10.1371/journal.ppat.1000819.s002 (0.51 MB GIF)
Figure S3 Lewis antigens are present on the H. pylori flagella.
Fluorescence microscopy of H. pylori J99 using an anti-Le
x
antibody confirmed the presence of Lewis antigens on the
membranous sheath covering the H. pylori flagella, indicated by
an arrow.
Found at: doi:10.1371/journal.ppat.1000819.s003 (0.28 MB GIF)
Figure S4 Partial waaLHP complementation. Purified LPS from
1: wild type H. pylori G27, 2: waaL mutant, 3: waaL complemented
was analyzed by Western blot using an anti-Le
y antibody. The
partial production of smooth LPS in the complemented strain is
indicated with an arrow. Protein marker standards were included
for reference.
Found at: doi:10.1371/journal.ppat.1000819.s004 (0.34 MB GIF)
Figure S5 Purification of WaaLHP-His10. WaaLHP-His10 purifi-
cation fractions using nickel affinity chromatography were run on
a 10% SDS-PAGE and proteins were stained with coomassie. 1:
loading sample; 2: flow through; 3: washing fraction; 4–9: elution
fractions 1–6 (1 ml was collected per elution fraction). The band
containing WaaLHP-His10 is indicated with an arrow. Its identity
was confirmed by mass spectrometry. Protein marker standards
were included for reference.
Found at: doi:10.1371/journal.ppat.1000819.s005 (0.50 MB GIF)
Figure S6 Validation of the mild acid hydrolysis protocol. (1) E.
coli LPS, (2) H. pylori G27 wild type LPS and (3) C. jejuni LLO in the
same conditions as applied for the in vitro ligation assay are shown
in a Western blot using anti-E. coli O16 antigen, anti-Le
y and HR6
anti-C. jejuni glycan antibodies, (A) not hydrolyzed and (B) after
mild acid hydrolysis. Mild acid hydrolysis affects UndPP-linked
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Protein marker standards were included for reference.
Found at: doi:10.1371/journal.ppat.1000819.s006 (0.51 MB GIF)
Figure S7 ATP is not required for H. pylori WaaL in vitro activity.
Ligation in vitro was performed (1) in the absence and (2) in the
presence of ATP (2 mM). Reaction samples were separated with
SDS-PAGE (15%) and were analyzed with (A) silver staining and
(B, C) Western blotting using the HR6 anti-C. jejuni glycan
antibody, whereby reaction samples were treated with mild acid in
(C), hydrolyzing the UndPP-linked glycan (substrate). Protein
marker standards were included for reference.
Found at: doi:10.1371/journal.ppat.1000819.s007 (0.51 MB GIF)
Figure S8 Wzk alignments. Alignments of translocase polypep-
tide sequences were done using MultiAlin (http://bioinfo.
genotoul.fr/multalin/multalin.html). (A) Alignments of Wzk
sequences from sequenced H. pylori strains G27, 26695, J99,
HPAG1 and P12. (B) Alignment of Wzk sequences from H. pylori
G27 and J99 with homologous sequences from Wolinella succinogenes
and Arcobacter butzleri and PglK from C. jejuni. (C) Alignment of Wzk
sequences from H. pylori G27 and J99 with homologous sequences
from Wolinella succinogenes and Arcobacter butzleri, PglK from C. jejuni
and MsbA sequences from H. pylori J99 and E. coli.
Found at: doi:10.1371/journal.ppat.1000819.s008 (0.49 MB GIF)
Figure S9 Glycan structures translocated by Wzk. Shown are
the glycan structures translocated by Wzk in this study. (A) H. pylori
O chains containing Lewis antigens. The positions of the fucose
residues can change (Skoglund et al., 2009, PLoS ONE). Shown
are terminal Le
y, terminal Le
x and internal Le
x with terminal Le
y.
(B) C. jejuni heptasaccharide (Young et al., 2002, J Biol Chem.). (C)
E. coli O16 antigen (Stevenson et al., 1994, J Bacteriol.).
Found at: doi:10.1371/journal.ppat.1000819.s009 (0.17 MB GIF)
Table S1 Oligonucleotides.
Found at: doi:10.1371/journal.ppat.1000819.s010 (0.04 MB
DOC)
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